Here's the live share price of Dr. Reddy's Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Dr. Reddy's Laboratories has gained 7.48% CAGR. Over the past year, the corresponding return has been -5.30%.
Dr. Reddy's Laboratories’s current P/E of 15.36x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Dr. Reddy's Laboratories | 0.44 | 4.51 | -1.66 | 12.60 | -5.30 | 14.60 | 7.48 |
Sun Pharmaceutical Industries | 0.04 | -2.29 | -5.26 | 0.81 | -12.60 | 21.69 | 25.45 |
Divi's Laboratories | -1.78 | -6.24 | -9.36 | 8.98 | 17.24 | 18.68 | 13.45 |
Cipla | -2.32 | 3.57 | 4.23 | 9.46 | -4.63 | 14.82 | 16.72 |
Torrent Pharmaceuticals | 0.62 | -0.23 | 13.90 | 20.10 | 4.02 | 33.07 | 20.80 |
Mankind Pharma | 3.23 | -2.51 | 8.05 | 11.49 | 3.27 | 21.45 | 12.37 |
Zydus Lifesciences | 3.40 | 5.63 | 6.13 | 14.26 | -9.05 | 39.82 | 22.33 |
Lupin | 2.27 | 3.90 | -2.97 | -3.66 | -15.39 | 43.67 | 15.92 |
Abbott India | -0.79 | -6.05 | -1.42 | -0.43 | 5.42 | 19.72 | 13.68 |
Alkem Laboratories | 0.58 | 8.45 | 10.17 | 13.64 | -15.02 | 20.67 | 13.59 |
Aurobindo Pharma | 1.69 | -3.24 | -9.87 | -4.33 | -31.81 | 24.63 | 5.64 |
Glenmark Pharmaceuticals | 6.87 | 0.24 | 29.73 | 48.29 | 20.31 | 76.91 | 34.51 |
Biocon | 4.45 | -2.35 | 10.03 | 12.06 | -4.96 | 7.51 | -2.93 |
Laurus Labs | 2.74 | 2.62 | 37.33 | 55.29 | 79.92 | 16.07 | 29.66 |
GlaxoSmithKline Pharmaceuticals | -0.24 | -2.23 | -19.74 | 3.15 | -1.27 | 24.44 | 11.30 |
Anthem Biosciences | 1.37 | 12.75 | 13.61 | 13.61 | 13.61 | 4.35 | 2.58 |
Cohance Lifesciences | 5.19 | -3.75 | -12.98 | -21.28 | -19.61 | 23.33 | 22.36 |
Ipca Laboratories | -3.18 | -6.24 | -3.59 | -1.93 | -7.37 | 14.67 | 5.57 |
Ajanta Pharma | 5.65 | -0.67 | 1.69 | 2.28 | -21.34 | 24.71 | 20.83 |
Gland Pharma | 1.95 | -3.11 | 16.77 | 20.77 | 0.66 | -8.34 | 0.90 |
Over the last one year, Dr. Reddy's Laboratories has declined 5.30% compared to peers like Sun Pharmaceutical Industries (-12.60%), Divi's Laboratories (17.24%), Cipla (-4.63%). From a 5 year perspective, Dr. Reddy's Laboratories has underperformed peers relative to Sun Pharmaceutical Industries (25.45%) and Divi's Laboratories (13.45%).
Day | SMA | EMA |
---|---|---|
5 | 1,264.79 | 1,260.91 |
10 | 1,267.11 | 1,261.22 |
20 | 1,247.76 | 1,258.56 |
50 | 1,264.79 | 1,258.28 |
100 | 1,248.65 | 1,252.15 |
200 | 1,237.53 | 1,246.72 |
In the latest quarter, Dr. Reddy's Laboratories saw a drop in promoter holding to 26.62%, while DII stake increased to 37.77%, FII holding fell to 25.33%, and public shareholding moved down to 10.00% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
---|---|---|---|
Parag Parikh Flexi Cap Fund | 1,12,17,622 | 1.26 | 1,424.97 |
SBI Nifty 50 ETF | 1,09,14,425 | 0.69 | 1,386.46 |
ICICI Prudential Value Discovery Fund | 93,22,942 | 2.2 | 1,184.29 |
Nippon India Large Cap Fund | 50,07,429 | 1.44 | 636.09 |
ICICI Prudential Balanced Advantage Fund | 48,86,509 | 0.96 | 620.73 |
ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund | 42,52,731 | 8.85 | 540.22 |
Nippon India Pharma Fund | 39,16,074 | 5.69 | 497.46 |
ICICI Prudential Bluechip Fund | 36,55,647 | 0.65 | 464.38 |
Mirae Asset Large & Midcap Fund | 34,47,751 | 1.08 | 437.97 |
UTI Nifty 50 ETF | 34,03,801 | 0.69 | 432.38 |
Price | (%) As on Invalid Date IST |
Open Interest | (%) |
High | |
Low | |
Open | |
Close | |
Contract Traded | |
Turnover (in lakhs) |
Date Time | Announcement |
---|---|
Sep 04, 2025, 11:45 PM IST | Dr. Reddy's Labs - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements)Regulations, 2 |
Sep 02, 2025, 5:01 PM IST | Dr. Reddy's Labs - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
Sep 01, 2025, 10:27 PM IST | Dr. Reddy's Labs - Announcement under Regulation 30 (LODR)-Change in Management |
Aug 29, 2025, 5:28 PM IST | Dr. Reddy's Labs - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS |
Aug 26, 2025, 10:16 PM IST | Dr. Reddy's Labs - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 |
Dr. Reddy's Laboratories Ltd. is a Public Limited Listed company incorporated on 24/02/1984 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L85195TG1984PLC004507 and registration number is 004507. Currently Company is involved in the business activities of Manufacture of other pharmaceutical and botanical products like hina powder etc.. Company's Total Operating Revenue is Rs. 23115.40 Cr. and Equity Capital is Rs. 83.40 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Dr. Reddy's Laboratories is ₹1,268.55 as on Sep 05, 2025.
The Dr. Reddy's Laboratories is operating in the Pharmaceuticals and health care Sector. It is classified as a Largecap stock on the BSE.
The market cap of Dr. Reddy's Laboratories is ₹105,874.11 Cr as on Sep 05, 2025.
Today’s highest and lowest price of Dr. Reddy's Laboratories are ₹1,272.00 and ₹1,249.55.
The 52-week high/low is the highest and lowest price at which Dr. Reddy's Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Dr. Reddy's Laboratories is ₹1,404.60 and 52-week low of Dr. Reddy's Laboratories is ₹1,025.90 as on Sep 05, 2025.
The Dr. Reddy's Laboratories has shown returns of 1.21% over the past day, 4.51% for the past month, -1.66% over 3 months, -5.3% over 1 year, 14.6% across 3 years, and 7.48% over 5 years.
P/E ratio of and PB ratio of Dr. Reddy's Laboratories are 15.36 and 3.93 on Sep 05, 2025. While the company gives a dividend yield of 0.63 per annum.